Home » Newsletters » BioWorld

BioWorld

Feb. 9, 2000

View Archived Issues

BioCryst's Flu Drug Moves Into Phase III, Triggering Milestone

Clinton Issues Order Banning Federal Genetic Discrimination

Other News To Note

Affymetrix Raising Another $150M Through Notes Sale

Adolor Seeks $72M To $84M As It Registers To Go Public

Crystallography Sees To Heart Of Key Enzyme That Builds Cell Wall Shielding Tuberculosis Bug

Alkermes, Lilly Collaborate On Inhaled Growth Hormone

Exelixis Expects $100M In IPO To Fund Genomics Programs

Praecis Finds Conditions Better As It Registers Again For IPO